Skip to main content
Clinical Trials/CTRI/2017/11/010428
CTRI/2017/11/010428Recruiting未知

Intensity modulated radiotherapy with IGRT for Post cricoid and upper esophageal cancer: Prospective observational study

Varian Medical Systems Inc0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1.Biopsy-proven squamous cell carcinoma of the post cricoid and upper esophagus, with AJCC 7th edition stage T1-3N0-1,2M0
  • 2.Lesions of the cervical and upper thoracic esophagus but not involving the mid and lower third of thoracic esophagus
  • 3.Suitable for radical treatment with RT alone or Concurrent Chemo-radiotherapy
  • 4.No significant co-morbidities that would interfere with treatment
  • 5.Reliable for follow-up and signed informed consent.
  • 6.Karnofsky performance status (KPS) between 70 and 100

Exclusion Criteria

  • 1.Age less than 18;
  • 2.Previous treatment (e.g. chemotherapy, radiation therapy, laser therapy or surgery) for esophageal or head and neck cancer (gastrostomy or PEG does not constitute exclusion criteria);
  • 3.Previous thoracic radiation therapy for any cause;
  • 4.Evidence of other uncontrolled malignancies;
  • 5.Severe compromised pulmonary function due to pulmonary disease eg. COPD
  • 6.Scoliosis/kyphosis;
  • 7.Failure to complete all baseline assessments required for the study.
  • 8.Dysfunctional larynx (gross exolaryngeal extension, need for tracheostomy)

Investigators

Sponsor
Varian Medical Systems Inc

Similar Trials